Direxion Daily Semiconductor Bull 3x Shares ETF
SOXL
VanEck Semiconductor ETF
SMH
Direxion Daily Real Estate Bull 3X Shares ETF
DRN
4
The Technology Select Sector SPDR® Fund
XLK
5
Direxion Daily Financial Bull 3X Shares ETF
FAS
US Stock MarketDetailed Quotes
Actinium (ATNM)
- 1.110
- -0.060-5.13%
Trading Apr 30 14:52 ET
34.83MMarket Cap-1.02P/E (TTM)
1.180High1.110Low102.56KVolume1.155Open1.170Prev Close115.33KTurnover0.33%Turnover RatioLossP/E (Static)31.37MShares1.94552wk High4.44P/B34.45MFloat Cap0.95252wk Low--Dividend TTM31.04MShs Float450.000Historical High--Div Yield TTM5.97%Range %0.952Historical Low1.125Avg Price1Lot Size
ATNM Stock Chart
Real-Time
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
ATNM Orderflow
Unit: --
ATNM Orderflow Trend
IntradayDayWeekMonth
No Data
Actinium (ATNM) News
Reinforced Buy on Actinium: Strengthening ATNM-400 Pan-Tumor Data and Expanding Actimab-A AML Opportunities Drive Pipeline Upside
Actinium Pharma Presents Preclinical Results For ATNM-400 Across Prostate, Lung, And Breast Cancer Models Presented At AACR Annual Meeting
Express News | Actinium Pharmaceuticals Inc - Atnm-400 Well Tolerated With No in Vivo Toxicities Observed at Efficacious Doses
Express News | Actinium Pharmaceuticals Inc - Atnm-400 Shows Efficacy in High and Low Psma-Expressing Prostate Cancer Models
Express News | Actinium Pharmaceuticals Inc - Atnm-400 Demonstrates Pan-Tumor Activity Across Prostate, Lung, and Breast Cancer Models
Express News | Actinium Pharmaceuticals Shares Are Trading Higher After the Company Announced That Two Abstracts, on ATNM-400 and Actimab-A, Respectively, Will Be Presented at the American Association for Cancer Research Annual Meeting 2026 on April 17-22, 2026
Actinium (ATNM) Stock Forum
$Actinium (ATNM.US)$ Reuters
just
Actinium Pharmaceuticals Inc - Atnm-400 Shows Efficacy in High and Low Psma-Expressing Prostate Cancer Models! Atnm-400 Well Tolerated With No in Vivo Toxicities Observed at Efficacious Doses
Atnm-400 Demonstrates Pan-Tumor Activity Across Prostate, Lung, and Breast Cancer Models
just
Actinium Pharmaceuticals Inc - Atnm-400 Shows Efficacy in High and Low Psma-Expressing Prostate Cancer Models! Atnm-400 Well Tolerated With No in Vivo Toxicities Observed at Efficacious Doses
Atnm-400 Demonstrates Pan-Tumor Activity Across Prostate, Lung, and Breast Cancer Models
1
$Actinium (ATNM.US)$ Reuters
1m
Actinium Pharmaceuticals Announces Atnm-400 Data Demonstrating Potent Efficacy in Triple-Negative Breast Cancer and Ability to Overcome Endocrine and Her2-Targeted Therapy Resistance Being Presented at the San Antonio Breast Cancer Symposium
1m
Actinium Pharmaceuticals Announces Atnm-400 Data Demonstrating Potent Efficacy in Triple-Negative Breast Cancer and Ability to Overcome Endocrine and Her2-Targeted Therapy Resistance Being Presented at the San Antonio Breast Cancer Symposium
$Actinium (ATNM.US)$
Actinium Pharmaceuticals Announces ATNM-400 Data Demonstrating Potent Efficacy in Triple-Negative Breast Cancer and Ability to Overcome Endocrine and HER2-Targeted Therapy Resistance Being Presented at the San Antonio Breast Cancer Symposium
Monday, 1st December at 8:45 am
Presentation to include new data in triple-negative disease, a breast cancer subtype with poor outcomes and limited viable treatment options
ATNM-400 overcomes HER2 therapy resistance and represent...
Actinium Pharmaceuticals Announces ATNM-400 Data Demonstrating Potent Efficacy in Triple-Negative Breast Cancer and Ability to Overcome Endocrine and HER2-Targeted Therapy Resistance Being Presented at the San Antonio Breast Cancer Symposium
Monday, 1st December at 8:45 am
Presentation to include new data in triple-negative disease, a breast cancer subtype with poor outcomes and limited viable treatment options
ATNM-400 overcomes HER2 therapy resistance and represent...
1
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)